Our work on the development of Abscisic Acid (ABA) biosynthetic inhibitors based was finally accepted by the United States Patent Office. It was based on the rational design of a small molecule to fit and stick into the primary biosynthetic 9-cis expoxycarotenoid diogenase enzyme involved in the biosynthesis of ABA in planta. This is related to our previous publication Boyd et al., 2009.
Innovating Protein Biochemistry into Biotechnology (Spring 2022)